SUPPRESSION OF ADVANCED GLYCATION AND LIPOXIDATION END PRODUCTS BY ANGIOTENSIN II TYPE-1 RECEPTOR BLOCKER CANDESARTAN IN TYPE 2 DIABETIC PATIENTS WITH ESSENTIAL HYPERTENSION
2013 ◽
Vol 59
(2)
◽
pp. 69-75
◽
2007 ◽
Vol 1
(3)
◽
pp. 189-199
◽